Erelzi^® (etanercept) 50mg solution for injection in pre-filled pen will be out of stock from early May until mid-July 2024. Homecare providers (Alcura, Healthnet and Sciensus) have sufficient stock to supply existing patients until mid/late May 2024.

The supply issues have been caused by a manufacturing failure resulting in delays in production and the implementation of global allocations. 

• Erelzi^® 50mg pre-filled syringes (PFS) remain available, however, they cannot support a full increase in demand.
• Benepali^® (etanercept) 50mg solution for injection in pre-filled pens remains available and can support a full increase in demand on an ongoing basis.
• Enbrel^® (etanercept) 50mg solution for injection in pre-filled pens remain available and can support a full increase in demand on an ongoing basis.

The SPS Medicines Supply Tool details any changes to resupply dates, updates to this communication and an up-to-date supply overview.

This National Patient Safety Alert provides further background, clinical information and actions for providers.